Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial
| Title: | Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial |
|---|---|
| Authors: | Yardley, Denise A., Ward, Patrick J., Daniel, Brooke R., Eakle, Janice F., Lamar, Ruth E., Lane, Cassie M., Hainsworth, John D. |
| Source: | In Clinical Breast Cancer October 2016 16(5):349-355 |
| Database: | ScienceDirect |
| ISSN: | 15268209 |
|---|---|
| DOI: | 10.1016/j.clbc.2016.05.006 |
| Published in: | Clinical Breast Cancer |
| Language: | English |